The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
JCI - Applying the discovery of the Philadelphia chromosome
shRNA Loss-of-Function Screen Identifies Alternate Pathway for BCR-ABL - Cellecta
![PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7afde5a58c37047c83cde7051c4024ff35912884/2-Figure1-1.png "PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar")
PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar
The Paradigm of Targeting an Oncogenic Tyrosine Kinase: Lesson from BCR-ABL | IntechOpen
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
Response and Resistance to BCR-ABL1-Targeted Therapies
BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
Bcr-Abl阻害 | Bcr-Abl Inhibition
IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
